Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph early_phase_1
1
20%
Ph not_applicable
1
20%
Ph phase_1
3
60%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
Phase 13 (60.0%)
N/A1 (20.0%)

Trials by Status

terminated120%
completed360%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
completedearly_phase_1

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

NCT01868087
completedphase_1

Pancreatic Clamp in NAFLD

NCT05724134
withdrawnphase_1

Dexamethasone/Pancreatic Clamp P&F

NCT06126354
terminatednot_applicable

Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT02590107
completedphase_1

Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects

NCT02034591

Clinical Trials (5)

Showing 5 of 5 trials
NCT01868087Early Phase 1

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Completed
NCT05724134Phase 1

Pancreatic Clamp in NAFLD

Completed
NCT06126354Phase 1

Dexamethasone/Pancreatic Clamp P&F

Withdrawn
NCT02590107Not Applicable

Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

Terminated
NCT02034591Phase 1

Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
5